Atherosclerosis;Athérosclérose

EMC - Cardiologie-Angeiologie

Volumn 2, Issue 4, 2005, Pages 436-458

  Bonnet, J ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Artery; Atherosclerosis; Cardiovascular diseases; Coronary artery disease

Indexed keywords

EID: 32544451967     PISSN: 17626137     EISSN: 17626137     Source Type: Journal    
DOI: 10.1016/j.emcaa.2005.09.011     Document Type: Short Survey

References (85)

1. Wolinsky H, Glagov S. A lamellar unit of aortic medial structure and function in mammals. Circ Res 1967;20:99-111.
2. Stary HC, Blankenhorn DH, Changler AB, Glagov S, Insull W, Richardson M, et al. A definition of the intima of human arteries and its atherosclerotic- prone regions. Circulation 1992;85:391-405.
3. Classification of atherosclerotic lesions: report of a study group. World Health Organization. WHO Techn Rep Ser 1958;143:1-20.
4. Stary HC, Chandler B, Glagov S, Guyton JR, Insull W, Rosenfeld ME, et al. A definition of initial fatty streak, and intermediate lesions of atherosclerosis. Arterioscler Thromb 1994;14:840-56.
5. Stary HC, Chandler B, Dinsmore RE, Fuster V, Glagov S, Insull W, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:1512-31.
6. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354-63.
7. Virmani R, Burke AP, Farb A. Sudden cardiac death. Cardiovasc Pathol 2001;10:211-8.
8. Ben-Horin S, Bardan E, Barshack I, Zaks N, Livneh A. Cholesterol crystal embolization to the digestive system: characterization of a common, yet overlooked presentation of atheroembollsm. Am J Gastroenterol 2003;98: 1471-9.
9. Eggebrecht H, Oldenburg O, Dirsch O, Haude M, Baumgart D, Welge D, et al. Potential embolization by atherosclerotic debris dislodged from aortic wall during cardiac catheterization: histological and clinical findings in 7,621 patients. Catheter Cardiovasc Interv 2000;49: 389-94 [see comments].
10. Tunick PA, Kronzon I. Atheromas of the thoracic aorta: clinical and therapeutic update. J Am Coll Cardiol 2000; 35:545-54.
11. Xu C, Zarins CK, Glagov S. Aneurysmal and occlusive atherosclerosis of the human abdominal aorta. J Vasc Surg 2001;33:91-6.
12. Bonser RS, Pagano D, Lewis ME, Rooney SJ, Guest P, Davies P, et al. Clinical and patho-anatomical factors affecting expansion of thoracic aortic aneurysms. Heart 2000;84:277-83.
13. Hayashi H, Matsuoka Y, Sakamoto I, Sueyoshi E, Okimoto T, Hayashi K, et al. Penetrating atherosclerotic ulcer of the aorta: imaging features and disease concept. Radiographics 2000;20:995-1005.
14. rd TM. Penetrating atherosclerotic ulcer of the descending thoracic aorta and arch. J Thorac Cardiovasc Surg 2004;127:1393-401.
15. Mehta RH, O'Gara PT, Bossone E, Nienaber CA, Myrmel T, Cooper JV, et al. Acute type A aortic dissection in the elderly: clinical characteristics, management, and outcomes in the current era. J Am Coll Cardiol 2002;40:685-92.
16. Svensson LG, Labib SB, Eisenhauer AC, Butterly JR. Intimal tear without hematoma: an important variant of aortic dissection that can elude current imaging techniques. Circulation 1999;99:1331-6.
17. Erbel R, Alfonso F, Boileau C, Dirsch O, Eber B, Haverich A, et al. Diagnosis and management of aortic dissection. Eur Heart J 2001;22:1642-81.
18. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986;6:131-8.
19. Lagrost L, Masson D, Chapman J. Lipoprotéines et métabolisme lipidique. In: Toussaint J, Jacob M, Lagrost L, Chapman J, editors. L'athérosclérose, Paris: Masson; 2003. p. 59-77.
20. Lagrost L. Regulation of cholesterol ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta 1994;1215:209-36.
21. Brown MG, Goldstein JL. A receptor mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
22. Williams KJ, Tabas I. The response to retention hypothesis of early atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:551-61.
23. Steinberg D, Parthasarathy S, Carew TE, Khov JC, Wittztum JL. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
24. Witztum JL, Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med 2001;11:93-102.
25. Napoli C, D'Armiento FP, Mancini FP, Postglione A, Witztum JL, Palumbo G, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997; 100:2680-90.
26. Wentworth Jr. P, McDunn JE, Wentworth AD, Takeuchi C, Nieva J, Jones T, et al. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 2002;298:2195-9.
27. Kume N, Kita T. Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis. Curr Opin Lipidol 2001;12:419-23.
28. Linton MF, Fazio S. Class A scavenger receptors, macrophages, and atherosclerosis. Curr Opin Lipidol 2001;12:489-95.
29. Herz J, Hui DY. Lipoprotein receptors in the vascular wall. Curr Opin Lipidol 2004;15:175-81.
30. Stone PH, Coskun AU, Yeghiazarians Y, Kinlay S, Popma JJ, Kuntz RE, et al. Prediction of sites of cornary atherosclerosis progression: In vivo profiling of endothelial shear stress, lumen, and outer vessel wall characteristics to predict vascular behavior. Curr Opin Cardiol 2003;18:458-70.
31. Resnick N, Yahav H, Schubert S, Wolfovitz E, Shay A. Signalling pathways in vascular endothelium activated by shear stress: relevance to atherosclerosis. Curr Opin Lipidol 2000;11:167- 77.
32. Porat RM, Grunewald M, Globerman A, Itin A, Barshtein G, Alhonen L, et al. Specific induction of tiel promoter by disturbed flow in atherosclerosis-prone vascular niches and flow-obstructing pathologies. Circ Res 2004;94:394-401.
33. Chen XL, Varner SE, Rao AS, Grey JY, Thomas S, Cook CK, et al. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 2003;278:703-11.
34. Shyy JY, Chien S. Role of integrins in endothelial mechanosensing of shear stress. Circ Res 2002;91:769-75.
35. Allen S. Lipid/vascular wall interaction. Curr Opin Cardiol 1998;13:439-46.
36. Schultz D, Harrison DG. Quest for fire: seeking the source of pathogenic oxygen radicals in atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20:1412-3 [editorial; comment].
37. Glass CK, Witztum JL. Atherosclerosis: The road ahead. Cell 2001;104:503-16.
38. Duplaa C, Couffinhal T, Labat L, Moreau C, Petit Jean ME, Daniel Lamaziere JM, et al. Monocyte-macrophage recruitment and endothelial adhesion protein expression in human atherosclerotic lesions. Atherosclerosis 1996;121: 253-66.
39. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000;102:833-9.
40. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1999;19:1518-25.
41. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997; 94:1931-6.
42. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999;85:e17-e24.
43. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973;70:1753-6.
44. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, et al. Proliferation in primary and restenotic coronary atherectomy tissue: Implications for antiproliferative therapy. Circ Res 1993;73:223-31.
45. Grainger DJ, Metcalfe JC, Grace M, Mosedale DE. Transforming growth factor-beta dynamically regulates vascular smooth muscle differentiation in vivo. J Cell Sci 1998;111: 2977-88.
46. Dufourcq P, Louis H, Moreau C, Daret D, Boisseau MR, Daniel Lamazière JM, et al. Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler Thromb Vasc Biol 1998;18:168-76.
47. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert RA, Coats S, et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Ore Res 1999;85:1179-85.
48. Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res 1985;56:139-45.
49. Aikawa M, Yamaguchi H, Yazaki Y, Nagai R. Smooth muscle phenotypes in developing and atherosclerotic human arteries demonstrated by myosin expression. J Atheroscler Thromb 1995;2:14-23.
50. Glagov S, Weisenberg E, Zarins C, Stankunavicius R, Kolettis G. Compensatory Enlargement of Human Atherosclerosis Coronary Arteries. N Engl J Med 1987;316:1371-5.
51. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75 [see comments].
52. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993;69:377-81.
53. Moreno PR, Bernardi VH, Lopezcuellar J, Newell JB, McMellon C, Gold HK, et al. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 1996;94:3098-102.
54. Falk E. Stable versus unstable atherosclerosis: clinical aspects. Am Heart J 1999;138(5Pt2):S421-5.
55. Kockx MM, Herman AG. Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 2000;45:736-46.
56. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001;103:934-40.
57. Kieffer N, Phillips D. Platelet membrane glycoproteins: functions in cellular interactions. Annu Rev Cell Biol 1990; 6:329-57.
58. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosisin plaque thrombogenicity. Circulation 1999;99: 348-53.
59. Tedgui A, Mallat Z. Smooth muscle cells: another source of tissue factor-containing microparticles in atherothrombosis? Circ Res 2000;87:81-2 [editorial;comment].
60. ACC/AHA, Guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction. J Am Coll Cardiol 2000;36:970-1062.
61. Yamagishi M, Terashima M, Awano K, Kijima M, Nakatani S, Daikoku S, et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol 2000;35:106-11.
62. Beckman JA, Ganz J, Creager MA, Ganz P, Kinlay S. Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arterioscler Thromb Vasc Biol 2001;21:1618-22.
63. Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002;106:804-8.
64. Pasqui AL, Di Renzo M, Bova G, Bruni F, Puccetti L, Pompella G, et al. T cell activation and enhanced apoptosis in non-ST elevation myocardial infarction. Clin Exp Med 2003;3:37-44.
65. Reeder GS. Contemporary diagnosis and management of unstable angina. Mayo Clin Proc 2000;75:953-7.
66. Bernard V, Pillois X, Dubus I, Benchimol D, Labouyrie JP, Couffinhal T, et al. The -308 G/A tumor necrosis factor-alpha gene dimorphism: a risk factor for unstable angina. Clin Chem Lab Med 2003;41:511-6.
67. Dichgans M. CADASIL: a monogenic condition causing stroke and subcortical vascular dementia. Cerebrovasc Dis 2002;13(suppl2):37-41.
68. Richey Sharrett A, Coady SA, Folsom AR, Couper DJ, Heiss G. Smoking and diabetes differ in their associations with subclinical atherosclerosis and coronary heart disease-the ARIC Study. Atherosclerosis 2004;172:143-9.
69. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002;287:2570-81.
70. Hooi JD, Kester AD, Stoffers HE, Rinkens PE, Knottnerus JA, Van Ree JW. Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. J Clin Epidemiol 2004;57:294-300.
71. Deng GG, Martin-McNulty B, Sukovich DA, Freay A, Halks-Miller M, Thinnes T, et al. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res 2003;92:510-7.
72. Pan JH, Lindholt JS, Sukhova GK, Baugh JA, Henneberg EW, Bucala R, et al. Macrophage migration inhibitory factor is associated with aneurysmal expansion. J Vasc Surg 2003; 37:628-35.
73. Carrell TW, Burnand KG, Wells GM, Clements JM, Smith A. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2002;105: 477-82.
74. Zoccali C. Cardiorenal risk as a new frontier of nephrology: research needs and areas for Intervention. Nephrol Dial Transplant 2002;17(suppl11):50-4.
75. Iadecola C, Gorelick PB. Converging pathogenic mechanisms In vascular and neu rodegenerative dementia. Stroke 2003;34:335-7.
76. Saltzman AJ, Waxman S. Angisocopy and ischemic heart disease. Curr Opin Cardiol 2002;17:633-7.
77. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004; 291:1071-80.
78. Brezinski M. Characterizing arterial plaque with optical coherence tomography. Curr Opin Cardiol 2002;17:648-55.
79. Zarrabi A, Gul K, Willerson JT, Casscells W, Naghavi M. Intravascular thermography: a novel approach for detection of vulnerable plaque. Curr Opin Cardiol 2002;17:656-62.
80. Toussaint JF, Southern JF, Fuster V, Kantor HL. 13C-NMR spectroscopy of human atherosclerotic lesions. Relation between fatty acid saturation, cholesteryl ester content, and luminal obstruction. Arterioscler Thromb 1994;14: 1951-7.
81. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999;353:1547-57.
82. Montaye M, De Bacquer D, De Backer G, Amouyel P. Overweight and obesity: a major challenge for coronary heart disease secondary prevention in clinical practice in Europe. Eur Heart J 2000;21:808-13.
83. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000;355:675-87.
84. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001;357: 995-1001.
85. Montaye M, Richard F, Lemaire B, Domanievitcz RM, Lenoir MF, Danet S, et al. Secondary prevention of coronary disease in France. Result of the EUROASPIRE study: the Lille register of ischemic cardiopathies. Arch Mal Coeur Vaiss 1998;91:1211-20.